BofA Securities Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Maintains Target Price $55

Moomoo NewsJan 16 06:31 ET · Ratings

Why Agios Pharmaceuticals (AGIO) Is the Top Small Cap Stock to Buy With the Highest Upside Potential

Yahoo FinanceJan 13 16:29 ET

Express News | Agios Announces Key 2025 Milestones for Innovative Rare Disease Portfolio

ReutersJan 13 07:00 ET

Press Release: Agios Announces Key 2025 Milestones for Innovative Rare Disease Portfolio

Dow JonesJan 13 07:00 ET

Agios' Supplemental New Drug Application for Its Thalassemia Treatment Gets FDA Nod

Seeking AlphaJan 8 08:30 ET

Cardurion Pharmaceuticals Appoints Charlotte Newman as Chief Business Officer

BusinesswireJan 8 08:00 ET